Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Shares Up 5.8 Percent on Strong Q1 Profit Growth

NEW YORK, May 3 (GenomeWeb News) - Shares in Beckman Coulter were up 5.78 percent, or $3.04, at $55.61 in mid-afrernoon trade after the company reported a 27-percent jump in first-quarter profit.


As GenomeWeb News reported this morning, Beckman said revenues for the three months ended March 31 declined 1.2 percent to $560 million from the $576 million year over year.


Profits for the period surged to $41.4 million from $32.6 million in the year-ago period.


Beckman said it expects second-quarter revenue to be between $620 million and $645 million, which would be improvements of between .3 percent and 4.4 percent above the $618.8 million the company posted for the second quarter last year.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.